Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86b20d650df19d9f19ef7bc5839d5547 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b467e406a1603dc27e80db919cb38fbe |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
filingDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b38d794e414eac8c7fe1397f274ff47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e6b1b80e81041ee4a62e93ff4d4382 |
publicationDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2007031412-A1 |
titleOfInvention |
Direct and indirect effector cell protease receptor-1 (EPR-1) Inhibitors as antiplatelet agents |
abstract |
Direct and indirect effector cell protease receptor-1 (EPR-1) inhibitors may be used for the treatment of conditions associated with platelet aggregation as antiplatelet agents. |
priorityDate |
2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |